How Selective Laser Trabeculoplasty and Meds Reduce the Diurnal Fluc…

AAO 2023

L. K Seibold

AAO 2024 Insights: Long-Term Risk of Steroid-Induced Ocular Hyperten…

AAO 2024 Insights

F. Price

Trabeculectomy Complications

Aakriti Garg Shukla

Mistakes to Avoid in Glaucoma Management

Joseph Sowka

AAO 2024 Insights: Goniotomy Outcomes and Predictors of Success - an…

AAO 2024 Insights

A. Li

Glaucoma Awareness Month: When to Treat People Who Have or May Have …

George Spaeth

Assessment of Risk for Glaucoma Development and Progression

Keck School of Medicine of USC

D. Heuer

Is it Myopia or Glaucoma?

The Glaucoma Foundation

S. Moghimi

Alternative Biomarkers for Glaucoma Detection

Keck School of Medicine of USC

B. Song

Sight + Sound Bites: Advancements in Glaucoma Treatment and Research…

The Eye & Ear Foundation of Pittsburgh

I. Conner

Management of Cataracts and Glaucoma - Role of MIGS

The Glaucoma Foundation

J. Panarelli

Light at the End of Tunnel Vision: The Latest Directions in Glaucoma…

The Glaucoma Foundation

J. Berdahl

AAO 2024 Insights: Six-Year Rate of Visual Field Progression in the …

AAO 2024 Insights

G. Montesano

Starting Glaucoma Therapy - Medications vs SLT vs Sustained Drug Del…

The Glaucoma Foundation

A. Realini

Managing Angle Closure - With and Without Glaucoma

The Glaucoma Foundation

S. Moghimi

Glaucoma Awareness Month: What's happening in Glaucoma in 2025

Iqbal Ike K. Ahmed

Uveitic Glaucoma: Goniotomy’s Role, Steroid Response

Kanwal Nischal

Treating Glaucoma in 2024

Boston University Chobanian & Avedisian School of Medicine

J. G. Nolan

Year in Review: New Technologies in Glaucoma and Cornea

John Berdahl

Neuroprotection in Glaucoma

Keck School of Medicine of USC

J. Do